SITC 2025 is theacronymfor theSociety for Immunotherapy of Cancer’svision for the future of cancer immunotherapy, which aims to cure cancer by stimulating the body’s own immune system to recognize and destroy cancer cells through biological therapies. SITC 2025 was launched in 2015 and aims to achieve its goals through four key pillars: research, education, advocacy, and patient engagement.
SITC 2025 is important because it provides a roadmap for the future of cancer immunotherapy and outlines the steps that need to be taken to achieve the goal of curing cancer. It also helps to raise awareness of cancer immunotherapy and its potential benefits, and advocates for policies that support research and development in this field. SITC 2025 has already had a significant impact on the field of cancer immunotherapy, and it is expected to continue to play a major role in the years to come.
